|
(2)
|
Xxxxxxxx xxxxxxxx xxx xxxxxxxx látky („xxxxxxxx“) xxxx x xxxxxxx x článkem 37 xxxxxxxx (XX) č. 1272/2008 xxxxxxxxxx návrhy xx xxxxxxxx harmonizované xxxxxxxxxxx x xxxxxxxx xxxxxxxxx xxxxx x xxxxxxxxxxx xxxx zrušení xxxxxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxx xxxxxxxxx jiných xxxxx. Xx xxxxxxx xxxxxxxxxx&xxxx;(2) x xxxxx xxxxxxx, xxxxx xxxxx Xxxxx xxx xxxxxxxxxx xxxxx („XXX“) xxxxxxxx, xxxxx x xxxxxxxxxx xxxxxxxxxxxx stran, je xxxxxx xxxxxx, aktualizovat xx zrušit xxxxxxxxxxxxx xxxxxxxxxxx x označení xxxxxxxxx xxxxx. Xxxxxxx xxxxxxxxxx výboru XXX xxxx:
|
—
|
xxxxxxxxxx xx dne 8. xxxxxx 2018 xxxxxxx xxxxxxxx xxxxxxx... %[X ≤ 70 %],
|
|
—
|
xxxxxxxxxx xx xxx 9. xxxxxx 2018 xxxxxxx xxxxxx x xxxxxxx xxxxxxx (x xxxxxxx &xx; 3 μx,xxxxx > 5 μx x xxxxxx xxxxx ≥ 3:1),
|
|
—
|
stanovisko xx xxx 8. xxxxxx 2018 xxxxxxx xxxxxxxxxxxxxxxxxxxxx, trimethoxy(vinyl)silanu,
|
|
—
|
stanovisko xx xxx 8. xxxxxx 2018 ohledně xxxx(2-xxxxxxxxxxxxx)xxxxxxxxxxx, 6-(2-xxxxxxxxxxxxx)-6-xxxxx-2,5,7,10-xxxxxxxx-6-xxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 8. června 2018 xxxxxxx xxxxxxxx-xxxxxxxxx,
|
|
—
|
xxxxxxxxxx ze xxx 8. června 2018 ohledně granulované xxxx,
|
|
—
|
xxxxxxxxxx xx dne 30. xxxxxxxxx 2018 xxxxxxx xxx (N-hydroxy-N-nitrosocyklohexylaminato-O,O’)-mědi, xxx(X-xxxxxxxxxx-xxxxxxxxx-xxxxx)-xxxx, [Cu-HDO],
|
|
—
|
stanovisko xx xxx 14. xxxx 2018 ohledně xxxxxxxxxx-xxxxxxxxx, [1] stannanu, xxxxxxx-, xxx(xxxx xxxxxxx) xxxxxxxx [2],
|
|
—
|
xxxxxxxxxx ze dne 30. xxxxxxxxx 2018 xxxxxxx xxxxxxx[xxx,x]xxxxxxxx, xxxxxxx[x,x]xxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 9. xxxxxx 2018 xxxxxxx xxxxxxxxxx (ISO), (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorbenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyklopentanolu,
|
|
—
|
stanovisko xx dne 8. xxxxxx 2018 ohledně xxx(2-(2-xxxxxxxxxxxxx)xxxxx)xxxxxx, xxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 8. xxxxxx 2018 ohledně xxxxxxxxxxxxxx (XXX), (2XX,3XX)-1-(4-xxxxxxxxxxx)-4,4-xxxxxxxx-2-(1X-1,2,4-xxxxxxx-1-xx)xxxxxx-3-xxx,
|
|
—
|
xxxxxxxxxx ze xxx 8. xxxxxx 2018 xxxxxxx 2,2-xxx(xxxxxxxxxx)xxxxxx-1,3-xxxxx,
|
|
—
|
xxxxxxxxxx xx dne 14. xxxx 2018 xxxxxxx xxxxxxxxx, (2E)-3,7-dimethylokta-2,6-dien-1-olu,
|
|
—
|
stanovisko xx xxx 28. xxxxx 2019 xxxxxxx 2-(4-terc-butylbenzyl)propionaldehydu,
|
|
—
|
stanovisko xx dne 9. xxxxxx 2018 ohledně XXXX-xxxxxxxxxx (ISO), X-xxxxx (4-xxxxx-2-xxxxxxxxxxxx)xxxxxxxxxxxxx, S-ethyl 4-xxxxx-x-xxxxxxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 9. xxxxxx 2018 ohledně xxxxxxxxxx-xxxxxxx,
|
|
—
|
xxxxxxxxxx xx dne 14. xxxx 2018 xxxxxxx 4-{[(6-xxxxxxxxxxxxx-3-xx)xxxxxx](2,2-xxxxxxxxxxxxx)xxxxx}xxxxx-2(5X)-xxx, flupyradifuronu,
|
|
—
|
stanovisko xx xxx 30. xxxxxxxxx 2018 xxxxxxx xxxxxxxxxxxxx-xxxxxxx (XXX), xxxxxx 4- [(4,5-xxxxxxx-3-xxxxxxx-4-xxxxxx-5-xxx-1X-1,2,4-xxxxxxx-1-xx)xxxxxxxxxxxxxxxxx]-5-xxxxxxxxxxxxx-3-xxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 9. xxxxxx 2018 xxxxxxx X-(+)-xxxxxx xxxxxxxx, (2X)-2-xxxxxxxxxxxxxxxx kyseliny,
|
|
—
|
stanovisko xx xxx 9. xxxxxx 2018 xxxxxxx 2-xxxxxxxxxxxx-xxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 8. xxxxxx 2018 xxxxxxx glyoxylové xxxxxxxx …%,
|
|
—
|
xxxxxxxxxx xx xxx 14. xxxx 2018 xxxxxxx xxxxxxx-X-(xxxxxxxxxxxxx)xxxxxxxxx, [xxxxxxxxxxx xxxxxxxx z xxxxxx-X-(xxxxxxxxxxxxx)xxxxxxxxx],
|
|
—
|
xxxxxxxxxx xx xxx 30. xxxxxxxxx 2018 xxxxxxx (xxxxx-XXX-xxxxx)xxxxxxxxxxx draselného, cyklohexyl(hydroxy)diazen-1-oxidu, xxxxxxxx soli, [X-XXX],
|
|
—
|
xxxxxxxxxx xx xxx 14. xxxx 2018 xxxxxxx xxxxxxxxxxx-xxxxxxxxxxx, N-ethyl-N,N-dimethylhexadekan-1-aminium-ethyl-sulfátu, xxxxxxxxxxx-xxxxx-xxxxxxx [XXX],
|
|
—
|
xxxxxxxxxx ze dne 9. xxxxxx 2018 xxxxxxx (2XX)-2-[4-(4-xxxxxxxxxxx)-2(xxxxxxxxxxxxxxx)xxxxx]-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxxx-2-xxx, xxxxxxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx dne 30. xxxxxxxxx 2018 xxxxxxx xxxxxxxxxxxxxxxx (ISO), 1-(4-{4-[5-(2,6-xxxxxxxxxxxx)-4,5-xxxxxxx-1,2-xxxxxx-3-xx]-1,3-xxxxxxx-2-xx}xxxxxxxxx-1-xx)-2-[5-xxxxxx-3-(xxxxxxxxxxxxxxx)-1X-xxxxxxx-1-xx]xxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 14. xxxx 2018 xxxxxxx xxxxxxxxx-xxxxx, (X-4)-xxx[1-(xxxxxxx-xxxxx-X)xxxxxxx-2(1X)-xxxxxxx-xxxxx-X]xxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 30. listopadu 2018 xxxxxxx 3-chlor-4-(chlormethyl)-1-[3-trifluormethyl)fenyl]pyrrolidin-2-onu, xxxxxxxxxxxxxxx (ISO),
|
|
—
|
stanovisko xx xxx 30. xxxxxxxxx 2018 ohledně 4,5-dichlor-2-oktyl-2H-isothiazol-3-onu, [XXXXX],
|
|
—
|
xxxxxxxxxx ze dne 8. xxxxxx 2018 xxxxxxx 2-xxxxxx-1,2-xxxxxxxxxxxx-3(2X)-xxx, [XXXX],
|
|
—
|
xxxxxxxxxx xx dne 30. xxxxxxxxx 2018 xxxxxxx 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-(3‘,4’,5’xxxxxxxxxxxxxxx-2-xx)xxxxxxx-4-xxxxxxxxxxx, fluxapyroxadu,
|
|
—
|
stanovisko ze xxx 8. června 2018 xxxxxxx N-(hydroxymethyl)akrylamidu, xxxxxxxxxxxxxxxxxx, [XXX],
|
|
—
|
xxxxxxxxxx xx xxx 15. xxxxx 2018 ohledně 5-xxxxx-1,3-xxxxxxxx-X-[2-(4-xxxxxxxxxxxx-2-xx)xxxxx]-1X-xxxxxxx-4-xxxxxxxxxxx, 2’-[(XX)-1,3-xxxxxxxxxxxxx]-5-xxxxx-1,3-xxxxxxxxxxxxxxx-4-xxxxxxxxxxxxx, xxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 30. listopadu 2018 xxxxxxx iprovalikarbu (XXX), isopropyl [(2X)-3-xxxxxx-1-{[1-(4-xxxxxxxxxxx)xxxxx]xxxxx}-1-xxxxxxxx-2-xx]xxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx dne 30. xxxxxxxxx 2018 xxxxxxx xxxxxxxxxxx (ISO), N-allyl-4,5-dimethyl-2(trimethylsilyl)thiofen-3-karboxamidu,
|
|
—
|
stanovisko xx dne 9. xxxxxx 2018 xxxxxxx xxxxxxx, xxxxxxx [xxxx xxxxxxxx xx studena xx xxxxx xxxxxxxx Xxxxxxxxxxx xxxxxx xxx xxxxxxxx, extrahovaný xxxxxxxxxxxxxx xxxxxx xxxxxxxxx],
|
|
—
|
xxxxxxxxxx xx xxx 8. xxxxxx 2018 xxxxxxx kyseliny xxxxxxx …%[C> 70 %],
|
|
—
|
xxxxxxxxxx z 9. xxxxxx 2018 xxxxxxx xxxxxxxxxxxxxxxxxxxxxxxxxxxx, [X4],
|
|
—
|
xxxxxxxxxx xx xxx 30. listopadu 2018 xxxxxxx xxxxxxxxx-xxxxxxx (XXX), O-[2-(diethylamin)-6-methylpyrimidin-4-yl]-O,O-dimethyl-fosforthioátu,
|
|
—
|
stanovisko ze 30. xxxxxxxxx 2018 xxxxxxx xxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 14. xxxx 2018 xxxxxxx xxxxxxxxxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 30. xxxxxxxxx 2018 ohledně 2-xxxxxxxxxx-10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxx-xxxxxxxxx, [XXXX],
|
|
—
|
xxxxxxxxxx ze xxx 30. listopadu 2018 xxxxxxx xxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 14. xxxx 2018 xxxxxxx 2-xxxxxxxxxxxxxx, ethylenglykol-monobutyl-etheru,
|
|
—
|
stanovisko ze xxx 30. xxxxxxxxx 2018 xxxxxxx m-bis(2,3-epoxypropoxy)benzenu, xxxxxxxxxx-xxxxxxxxxx-xxxxxx,
|
|
—
|
xxxxxxxxxx ze xxx 14. září 2018 xxxxxxx tribenuron-methylu (ISO), xxxxxx 2-[X-(4-xxxxxxx-6-xxxxxx-1,3,5-xxxxxxx-2-xx)-X-xxxxxxxxxxxxxxxxxxxxxxxx]xxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 8. června 2018 ohledně xxxxxxxxxxxxx (XXX), xxxxxx (E)-2-{2-[6-(2-kyanofenoxy)pyrimidin-4-yloxy]fenyl}-3-methoxyakrylátu,
|
|
—
|
stanovisko xx dne 9. xxxxxx 2018 xxxxxxx xxxxxxxxxxxx (XXX), (XX)-2-xxxxxx-2,3-xxxxxxx-3,3-xxxxxxxxxxxxxxxxxx-5-xx-xxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 30. xxxxxxxxx 2018 xxxxxxx 2,4-xxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx ze xxx 14. xxxx 2018 xxxxxxx mesotrionu (ISO), 2-[4-(xxxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1,3-xxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 30. xxxxxxxxx 2018 xxxxxxx okthilinonu (ISO), 2-xxxxx-2X-xxxxxxxxxx-3-xxx, [OIT],
|
|
—
|
stanovisko xx xxx 14. xxxx 2018 ohledně hymexazolu (XXX), 3-xxxxxxx-5-xxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 30. xxxxxxxxx 2018 xxxxxxx xxxxxxxxxxxx (XXX), trans-5-(4-chlorfenyl)-N-cyklohexyl-4-methyl-2-oxo-3-thiazolidin-karboxamidu,
|
|
—
|
stanovisko xx xxx 9. xxxxxx 2018 ohledně pymetrozinu (XXX), (X)-4,5-xxxxxxx-6-xxxxxx-4-(3-xxxxxxxxxxxxxxx-xxxxx)-1,2,4-xxxxxxx-3(2X)-xxx,
|
|
—
|
xxxxxxxxxx xx xxx 9. xxxxxx 2018 xxxxxxx xxxxxxxxxxxx (XXX), xxxxxxx xxxxx: [2,4-xxxxx-(2-xxxxxx-1-xx)xxxxxxxxxxxx-3-xx]xxxxxx(1X)-xxx-xxxxxxxxxxxxxx, [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthematu,
|
|
—
|
stanovisko ze xxx 14. září 2018 xxxxxxx-xxxxx, xxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx ze dne 8. xxxxxx 2018 xxxxxxx xxx(α,α-xxxxxxxxxxxxxx)-xxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 9. března 2018 xxxxxxx rozvětveného xxxxxxxxxxxxxxx,
|
|
—
|
xxxxxxxxxx xx xxx 30. xxxxxxxxx 2018 xxxxxxx hexyl 2-(1-(xxxxxxxxxxxxxxxxxxxxxxxx) xxxxxxxxx)xxxxxxxx, xxxxx 2-[4-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxx]xxxxxxxx.
|
|